Willingness to bear adversity and beliefs about the curability of advanced cancer in older adults
Open Access
Abstract
Background: Older patients with advanced cancer who are 100% certain they will be cured pose unique challenges for clinical decision making, but to the authors’ knowledge, the prevalence and correlates of absolute certainty about curability (ACC) are unknown. Methods: Cross‐sectional data were collected in a geriatric assessment trial. ACC was assessed by asking patients, “What do you believe are the chances that your cancer will go away and never come back with treatment?” Response options were 100% (coded as ACC), >50%, 50/50, <50%, 0%, and uncertain. The willingness to bear adversity in exchange for longevity was assessed by asking patients to consider trade‐offs between survival and 2 clinical outcomes that varied in abstractness: 1) maintaining quality of life (QOL; an abstract outcome); and 2) specific treatment‐related toxicities (eg, nausea/vomiting, worsening memory). Logistic regression was used to assess the independent associations between willingness to bear adversity and ACC. Results: Of the 524 patients aged 70 to 96 years, approximately 5.3% reported that there was a 100% chance that their cancer would be cured (ACC). ACC was not found to be significantly associated with willingness to bear treatment‐related toxicities, but was more common among patients who were willing to trade QOL for survival (adjusted odds ratio, 4.08; 95% CI, 1.17‐14.26). Conclusions: Patients who were more willing to bear adversity in the form of an abstract state, namely decreased QOL, were more likely to demonstrate ACC. Although conversations regarding prognosis should be conducted with all patients, those who are willing to trade QOL for survival may especially benefit from conversations that focus on values and emotions.Keywords
Funding Information
- National Cancer Institute (R01 CA177592 (Mohile), R01CA168387 (Duberstein), UG1 CA189961)
This publication has 36 references indexed in Scilit:
- Patients' Expectations about Effects of Chemotherapy for Advanced CancerNew England Journal of Medicine, 2012
- Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter StudyJournal of Clinical Oncology, 2011
- Association of Cancer With Geriatric Syndromes in Older Medicare BeneficiariesJournal of Clinical Oncology, 2011
- Associations of social networks with cancer mortality: A meta-analysisCritical Reviews in Oncology/Hematology, 2010
- Racial and Ethnic Differences in Hospice Use Among Patients With Heart FailureArchives of internal medicine (1960), 2010
- Health Care Costs in the Last Week of LifeArchives of internal medicine (1960), 2009
- Health Literacy not Race Predicts End-of-Life Care PreferencesJournal of Palliative Medicine, 2008
- Racial/Ethnic Differences in Physician Distrust in the United StatesAmerican Journal of Public Health, 2007
- Why Do Patients Choose Chemotherapy Near the End of Life? A Review of the Perspective of Those Facing Death From CancerJournal of Clinical Oncology, 2006
- Linking decision-making research and cancer prevention and control: Important themes.Health Psychology, 2005